From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Decision Making In Hepatitis B – NT Version

First published:

March 2025

Last published:

2024

Overview

This resource supports clinical decision-making in hepatitis B, including who to test, how to test and interpret serology, how to conduct initial assessment, and how to conduct ongoing monitoring. It also provides an overview of the natural history of chronic hepatitis B, which can be used when making decisions about management and treatment.